Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
will work in an international and friendly environment. The research project will involve work with murine and human cellular systems (bone marrow stromal stem cells) and transgenic animal models
-
Bone Marrow/Stem Cell Transplantation and Cellular Therapy (BMT/CT) and the Outpatient Migration Program Provide care and direct management of adult patients with malignant myeloid and lymphoid
-
), 0.7 FTE Advanced Practice Professional (either NP or PA) will be hired to fill this job opening. This position will rotate between Adult Inpatient Bone Marrow/Stem Cell Transplantation and Cellular
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 3 days ago
for candidates with experience in background in one of these areas: proteomics, electrophysiology, microscopy, ion channels, gene therapy, synaptic physiology, biophysics advanced molecular biology, stem cells
-
Postgraduate Research Assistant, you will be directly involved in the day-to-day culture and maintenance of induced pluripotent stem cells (iPSC), differentiation of iPSCs into cardiomyocytes in 2D and 3D
-
. Our group works on basic science projects on gene regulation in blood stem cells (e.g. Frömel et al., Cell 2025 ), and more translational projects in the context of acute myeloid leukemia (AML) and pre
-
immunological research in complex nonhuman primate models. Ensures excellent animal care and welfare. Dr. Kean's research program is focused on the immunology of hematopoietic stem cell transplantation, tolerance
-
injury, stroke, or peripheral nerve injury, b) stem cell or extracellular vehicle or exosome therapy, c) genetic modification of animal models, in vivo electrophysiology. We offer multifaceted scientific
-
with primary intestinal stem cell culture is a plus. Preferred Qualifications Education: No additional education unless stated elsewhere in the job posting. Certifications/Professional Licenses
-
. Dynamic preservation using perfusion machines allows control of IR, and we have demonstrated the efficacy of a cellular therapy derived from urine progenitor cells. Despite the protective and promising